Kexing Biopharm's GB18 project received clearance of IND application from NMPA and FDA

Kexing Biopharm's GB18 project received clearance of IND application from NMPA and FDA#Kexing #Biopharm039s #GB18 #project…

Capricor: High-Reward DMD Treatment Bet With Strong Data And Looming FDA Decision

Capricor: High-Reward DMD Treatment Bet With Strong Data And Looming FDA Decision #Capricor #HighReward #DMD #Treatment…

FDA tightens requirements for COVID vaccine, adding trials for healthy adults

FDA tightens requirements for COVID vaccine, adding trials for healthy adults#FDA #tightens #requirements #COVID #vaccine #adding…

US FDA advisers to consider if new COVID shots should target LP.8.1 subvariant

US FDA advisers to consider if new COVID shots should target LP.8.1 subvariant#FDA #advisers #COVID #shots…

NeurAxis Soars on Groundbreaking FDA Clearance: A Game-Changer for Pediatric Care!

The Big News Driving the Surge NeurAxis dropped a bombshell this morning, announcing that its IB-Stim…

FDA approves Novavax COVID vaccine with new conditions

FDA approves Novavax COVID vaccine with new conditions#FDA #approves #Novavax #COVID #vaccine #conditions

Serena-backed health tech lands first FDA approval for home cervical cancer test

For the first time, the FDA has just approved a device that lets people screen for…

FDA Approves the AVMAPKI™ FAKZYNJA™ Combination Therapy as the First-Ever Treatment for Adult Patients with KRAS-mutated Recurrent Low-Grade Serous Ovarian Cancer

FDA Approves the AVMAPKI™ FAKZYNJA™ Combination Therapy as the First-Ever Treatment for Adult Patients with KRAS-mutated…

OpenAI and the FDA are reportedly discussing AI for drug evaluations

OpenAI has met with officials from the U.S. Food and Drug Administration (FDA) to discuss the…

US FDA advisers to discuss COVID-19 vaccine recommendations

US FDA advisers to discuss COVID-19 vaccine recommendations#FDA #advisers #discuss #COVID19 #vaccine #recommendations

Sarepta, other biotech stocks tumble as FDA appoints new CBER director

Sarepta, other biotech stocks tumble as FDA appoints new CBER director#Sarepta #biotech #stocks #tumble #FDA #appoints…

Exclusive-US cancels FDA bargaining session over layoffs, union says

Exclusive-US cancels FDA bargaining session over layoffs, union says#ExclusiveUS #cancels #FDA #bargaining #session #layoffs #union

Cytokinetics stock falls on FDA delay for heart drug

Cytokinetics stock falls on FDA delay for heart drug#Cytokinetics #stock #falls #FDA #delay #heart #drug

FDA delays Vanda Pharmaceuticals drug hearing

FDA delays Vanda Pharmaceuticals drug hearing#FDA #delays #Vanda #Pharmaceuticals #drug #hearing

uniQure: AMT-130 For HD Progresses Forward With Q2 2025 FDA Meeting

uniQure: AMT-130 For HD Progresses Forward With Q2 2025 FDA Meeting #uniQure #AMT130 #Progresses #FDA #Meeting

New Simplera Sync™ sensor for the MiniMed™ 780G System now FDA approved

New Simplera Sync™ sensor for the MiniMed™ 780G System now FDA approved#Simplera #Sync #sensor #MiniMed #780G…

UniQure N.V. (QURE) Soars on FDA Breakthrough Therapy Designation for Huntington’s Disease Treatment

As of this writing, UniQure N.V.’s stock price has surged 35.89% to $12.79 per share after…

Nanox’s Breakthrough FDA Clearance: What It Means for Investors and the Medical Imaging Industry

As of this writing, Nanox (NASDAQ:NNOX) has seen a significant gain in today’s market, with its…

Schrödinger Poised For Growth As FDA Shifts Away From Animal Testing (Upgrade)

Schrödinger Poised For Growth As FDA Shifts Away From Animal Testing (Upgrade) #Schrödinger #Poised #Growth #FDA…

Autonomix to begin U.S. clinical studies for FDA approval

Autonomix to begin U.S. clinical studies for FDA approval#Autonomix #U.S #clinical #studies #FDA #approval

FDA Shake-Up Rocks Moderna Stock As Regulatory Risks Mount (Downgrade)

FDA Shake-Up Rocks Moderna Stock As Regulatory Risks Mount (Downgrade) #FDA #ShakeUp #Rocks #Moderna #Stock #Regulatory…

Vaxcyte: Plunge On FDA Top Regulator Resigning Generates Buying Opportunity

Vaxcyte: Plunge On FDA Top Regulator Resigning Generates Buying Opportunity #Vaxcyte #Plunge #FDA #Top #Regulator #Resigning…